SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23p19 ANTIBODIES

The present invention provides high concentration solution formulations of anti-human interleukin-23 p19 (IL-23p19) antibody hum13B8-b, and their use in treating various disorders. La présente invention concerne des formulations en solution haute concentration d'anticorps anti-interleukine huma...

Full description

Saved in:
Bibliographic Details
Main Authors BADKAR, ANIKET, KASHI, RAMESH, S
Format Patent
LanguageEnglish
French
Published 19.06.2014
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention provides high concentration solution formulations of anti-human interleukin-23 p19 (IL-23p19) antibody hum13B8-b, and their use in treating various disorders. La présente invention concerne des formulations en solution haute concentration d'anticorps anti-interleukine humaine-23 p19 (IL-23p19) hum13B8-b, et leur utilisation pour traiter divers troubles.
Bibliography:Application Number: WO2013US73825